Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protagonist Therapeutics (PTGX) Tax Provisions (2018 - 2025)

Protagonist Therapeutics' Tax Provisions history spans 5 years, with the latest figure at $638000.0 for Q4 2025.

  • For Q4 2025, Tax Provisions fell 68.42% year-over-year to $638000.0; the TTM value through Dec 2025 reached $838000.0, down 80.14%, while the annual FY2025 figure was $838000.0, 80.14% down from the prior year.
  • Tax Provisions for Q4 2025 was $638000.0 at Protagonist Therapeutics, up from $200000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $3.3 million in Q1 2024 and bottomed at -$650000.0 in Q2 2024.